0000000000072085

AUTHOR

Olivier Raguin

showing 3 related works from this author

DOTAGA-Trastuzumab. A New Antibody Conjugate Targeting HER2/Neu Antigen for Diagnostic Purposes.

2012

International audience; Improved bifunctional chelating agents (BFC) are required for indium-111 radiolabeling of monoclonal antibodies (mAbs) under mild conditions to yield stable, target-specific agents. 2,2',2″-(10-(2,6-Dioxotetrahydro-2H-pyran-3-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid (DOTAGA-anhydride) was evaluated for mAb conjugation and labeling with indium-111. The DOTA analogue was synthesized and conjugated to trastuzumab-which targets the HER2/neu receptor-in mild conditions (PBS pH 7.4, 25 °C, 30 min) and gave a mean degree of conjugation of 2.6 macrocycle per antibody. Labeling of this immunoconjugate with indium-111 was performed in 75% yield after 1 h a…

Models MolecularImmunoconjugatesReceptor ErbB-2Pharmaceutical Science[CHIM.THER]Chemical Sciences/Medicinal Chemistry[ SDV.CAN ] Life Sciences [q-bio]/CancerMicechemistry.chemical_compound0302 clinical medicineTrastuzumabBreastMice Inbred BALB C0303 health sciencesbiologyChemistry[CHIM.ORGA]Chemical Sciences/Organic chemistryIndium Radioisotopes[ CHIM.COOR ] Chemical Sciences/Coordination chemistry[ CHIM.THER ] Chemical Sciences/Medicinal Chemistry3. Good healthBiochemistry030220 oncology & carcinogenesisMonoclonalFemaleAntibody[CHIM.RADIO]Chemical Sciences/Radiochemistry[ CHIM.RADIO ] Chemical Sciences/RadiochemistryBiotechnologymedicine.drugBiodistributionmedicine.drug_classBiomedical EngineeringBreast NeoplasmsBioengineering[SDV.CAN]Life Sciences [q-bio]/CancerAntibodies Monoclonal HumanizedMonoclonal antibodyAnhydridesHeterocyclic Compounds 1-Ring03 medical and health sciences[ CHIM.ORGA ] Chemical Sciences/Organic chemistryCell Line TumormedicineAnimalsHumansDOTA[CHIM.COOR]Chemical Sciences/Coordination chemistry030304 developmental biologyTomography Emission-Computed Single-PhotonPharmacologyOrganic ChemistryTrastuzumabMolecular biologyIn vitroImmunoconjugatebiology.protein
researchProduct

Abstract 4082: Preclinical assessment of external or targeted radiotherapy in combination with immunotherapies and co-development of companion imagin…

2019

Abstract Immunotherapies have proven to be highly efficient for cancer treatments and combination with either internal vectorized or external radiotherapies can enhance this efficacy through notably increasing tumor immune infiltrate. The clinical evaluation of such combination therapies requires expertise and exquisite processes in multiple fields, immunotherapy, radiotherapy and nuclear medicine. Similarly, this applies into preclinical settings for assessing proof of concept of novel combinations. Herein, we will present our preclinical evaluation process to combine external or internal (i.e. lutetium-177 radiolabeled molecule) radiotherapy with immunotherapies that include radiochemistr…

OncologyCancer Researchmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCancerImmunotherapymedicine.diseaseImmune checkpointRadiation therapyOncologyIn vivoRadioresistanceInternal medicineHumanized mousemedicinebusinessCompanion diagnosticCancer Research
researchProduct

Application of the optically stimulated luminescence (OSL) technique for mouse dosimetry in micro-CT imaging

2013

International audience; Purpose: Micro-CT is considered to be a powerful tool to investigate various models of disease on anesthetized animals. In longitudinal studies, the radiation dose delivered by the micro-CT to the same animal is a major concern as it could potentially induce spurious effects in experimental results. Optically stimulated luminescence dosimeters (OSLDs) are a relatively new kind of detector used in radiation dosimetry for medical applications. The aim of this work was to assess the dose delivered by the CT component of a micro-SPECT (single-photon emission computed tomography)/CT camera during a typical whole-body mouse study, using commercially available OSLDs based o…

[SDV.IB.IMA] Life Sciences [q-bio]/Bioengineering/Imaging[ INFO.INFO-IM ] Computer Science [cs]/Medical Imaging[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging[INFO.INFO-IM] Computer Science [cs]/Medical Imaging[INFO.INFO-IM]Computer Science [cs]/Medical Imaging[ SDV.IB.IMA ] Life Sciences [q-bio]/Bioengineering/Imaging
researchProduct